Healthcare ❯ Pharmaceuticals ❯ Drug Development

Clinical Trials

FDA Approval Regulatory Approval Obesity Treatments Oncology Lenacapavir FDA Approvals Nanobody Technology Bepirovirsen Weight Loss Drugs FDA Regulations

Novartis Faces Investor Backlash After Second Late‑Stage Trial Failure

The company is reviewing full del‑desiran data to guide regulator talks with remibrutinib's October readouts serving as the next major test.

Teva’s Experimental Antibody Prevents Gluten‑Triggered Intestinal Damage in Mid‑Stage Celiac Trial

FDA Expands Approval of J&J’s Imaavy to Treat Warm Autoimmune Hemolytic Anemia

GLP-1 Drugs Reshape Obesity Care

BioCryst Cuts Internal Discovery After Q2 ORLADEYO Gains and Pediatric Rollout

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

GSK Reports Q2 Beat and Unveils £1.9 Billion Savings Plan

AstraZeneca Beats Q2 Estimates and Reaffirms 2026 Guidance

Novartis Returns to Sales Growth as New Drugs Offset Entresto Slump

Kalshi Opens Betting Markets for Phase 3 Drug Trials and FDA Decisions

Sinopia’s SB-0110 Boosts Levodopa Benefit and Cuts Dyskinesia in Animal Models

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

HSE Refers Skyclarys Reimbursement to Rare Diseases Review Committee

Fulcrum Halts Pociredir Development After FDA Flags PRC2 Cancer Risk

New Hepatitis B Drug Produces Functional Cure in About One in Five Patients

Bepirovirsen Achieves Functional Cure in About One in Five People With Chronic Hepatitis B

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

Cormedix Lifts 2026 Outlook After Q1 Beat, Sets H2 FDA Filing Plan for Rizzeo

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose